IDEXX Laboratories, Inc. Share Price and Company Fundamentals



Price
$396.68
Change
-3.610 (-0.902%)
52 week
318.5 - 695.18

Last traded: Today at 8:00 PM

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Key Metrics

PE ratio

51.78

PB ratio

72.92

Dividend yield

0.00%

Beta

1.14

Market cap

-

Enterprise value

-

Company profile

Industry / SectorDiagnostics & Research / Healthcare
Full time employees10000
Websitehttps://www.idexx.com
Mailing addressOne IDEXX Drive Westbrook ME 04092 United States
Phone / Fax207 556 0300 / 207 556 4346

Dividends

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

IDEXX Laboratories, Inc. paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IDXX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

IDXX's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on IDEXX Laboratories, Inc..

NameTitleAgeTotal Pay
Mr. Jonathan J. MazelskyPres, CEO & Director603.07M
Mr. Brian P. McKeonCFO, Exec. VP & Treasurer591.43M
Mr. James F. PolewaczykExec. VP & Chief Commercial Officer571.19M
Mr. Michael J. LaneExec. VP and GM of Reference Laboratories & Information Technology531.19M
Dr. Nimrata Khatra Hunt P.E., Ph.D.Exec. VP and GM - Point of Care Diagnostics & Worldwide Operations531.18M
Mr. John HartSr. VP of Worldwide Operations
Mr. Jeffery D. ChadbourneSr. Director of Accounting & Financial Reporting45
Dr. Martin Smith Ph.D.Exec. VP & CTO53
Mr. Ken GradySr. VP & Chief Information Officer
Ms. Sharon E. UnderbergExec. VP, Gen. Counsel, & Corp. Sec.60

Profitability and management effectiveness

Profit margin

20.07%

Operating margin

25.77%

Return on assets

21.23%

Return on equity

110.17%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of IDEXX Laboratories, Inc. is and its enterprise value is .

The IDXX's stocks Beta value is 1.14 making it 14% more volatile compared to NASDAQ market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Frequently Asked Questions

1. What is IDEXX Laboratories, Inc.'s Stock Symbol?

IDEXX Laboratories, Inc. trades on NASDAQ under the ticker symbol "IDXX".

2. What is IDEXX Laboratories, Inc.'s stock price today?

One share of IDXX stock can currently be purchased for approximately $396.68.

3. How can I contact IDEXX Laboratories, Inc.?

IDEXX Laboratories, Inc.'s mailing address is One IDEXX Drive Westbrook ME 04092 United States. The company can be reached via phone at 207 556 0300.

4. What is IDEXX Laboratories, Inc.'s official website?

The official website of IDEXX Laboratories, Inc. is https://www.idexx.com.